CV Sciences launches PlusHLTH.com direct-to-consumer site for PlusHLTH products
CVSI•Product rollout and brand-building plans
Management framed the site as a strategic base for new product rollouts, consumer education, and higher-margin brand building in healthy aging.
+PlusHLTH currently sells non-cannabinoid supplements and a plant-based protein product, with further line expansion planned across new formats.
CV Sciences expands direct-to-consumer platform
CV Sciences launched PlusHLTH.com to scale its direct-to-consumer platform beyond cannabinoids, widening its addressable health and nutrition market.
The move gives the +PlusHLTH line a dedicated digital channel, positioning PlusCBDOil.com to stay focused on hemp-derived CBD.
Related News
Openlane prices 8 million-share secondary offering by Apax-advised Ignition fund
OPLN•
Central Puerto 1H FY26 net profit rises 88.77% to ARS 332.39 billion; revenue more than doubled to ARS 1.04 trillion
CEPU•
